Global semiconductor technology and equipment firm Revasum, Inc. (ASX: RVS, ‘Revasum’ or ‘the Company’) is pleased to announce the appointment of Mr. Alejandro Garcia as the Company’s Chief Operating Officer (COO), as of 3 January 2022.
Garcia will be responsible for leading Revasum’s operational processes and manufacturing systems and guiding the infrastructure scale-up of the Company’s silicon and silicon carbide (SiC) wafer grinding and polishing equipment technology.
Revasum’s new COO has great industry experience
Work history
Mr. Garcia is a highly skilled COO with 30 years of experience in various roles in ISO 9001 quality systems, manufacturing process systems, supply-chain logistics and business development in the semiconductor capital equipment, engineering and healthcare industries.
He has technical expertise in high purity gas and liquid distribution modules, electro-mechanical wafer substrate cleaning and metrology platforms.
Mr. Garcia commenced his career in quality control at Ultra Clean Holdings, Inc. (UCT), which develops subsystems and ultra-high purity cleaning services for the semiconductor industry.
He was Group Director, Global Operations for Ontrak Systems, Inc. which provides semiconductor capital equipment for chemical mechanical planarization.
For two years, he was Quality Assurance Director at Wolfe Engineering Inc., responsible for corporate policies, operation procedures, process flows and supply chain qualification.
He has also held Chief Operating Officer and Director roles at Wienhoff Drug Testing (Group Companies) & Norchem Laboratories, and Global Drug Testing Labs, Inc.
Most recently, Mr. Garcia has been working in Class IIb and III medical device remediation compliance and senior project management roles in pharmaceutical companies, including Johnson & Johnson’s DePuy Synthes, and Ethicon, Inc., and Roche MCM in New Jersey.
Education history
He holds an MBA, Operations from Saint Mary’s College of California, Moraga, and a Bachelor of Science, Information Systems Management, from the University of San Francisco.
Revasum President and Chief Executive Officer, Rebecca Shooter-Dodd, said “We are very pleased to welcome Alejandro to the executive team.”
“He has the right balance of skills and expertise around operation process systems management, quality audit and control, plus business development, that Revasum needs.”
“Central to this is expanding our manufacturing lines to meet new and expected orders for our equipment as the global demand for silicon and silicon carbide semiconductor equipment and technology grows to meet end-product requirements. We have recorded a solid year of progress and will commence FY22 with a strong backlog for equipment and spares.”
Alejandro Garcia, Chief Operating Officer, Revasum made these remarks on his appointment.
“I’m joining Revasum at an exciting time as it positions to advance and grow the next generation of silicon carbide grinding and polishing equipment.”
“Revasum has a significant opportunity to support emerging technologies requiring new product platforms and process development solutions. The team is focused on remaining at the forefront of technical innovation with the most advanced SiC polishing process platforms.”
Revasum released its business and market outlook report
In the past fortnight, Revasum has shipped a piece of equipment to a customer.
The Company now has Purchase Orders confirmed for seven pieces of equipment and a US$8.2 million backlog as at 21 December 2021. Outstanding orders are for Revasum’s 6DZ Silicon Polisher, 7AF-HMG Silicon Carbide (SiC) Grinder and 6EZ SiC Polisher.
As previously announced, based on forecasted customer demand, Revasum expects to ship 40 – 50 tools in FY22 and FY23 across its grinding and polishing product lines.
Revasum recently formed a partnership with California-based manufacturer, Owens Design, to ensure the Company is able to meet demand for its products in the medium term.
Revasum sees FY22 revenue in the range of US$25.0 million – US$35.0 million. This range represents a 60%-125% increase in total revenue from FY21 – FY22. Revasum continues to forecast FY21 total revenue between US$13.3 million – US$15.6 million.
